National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

trimethoprim-sulfamethoxazole
A synthetic combination of two antibacterial agents, trimethoprim and sulfamethoxazole. This synergistic combination, also known as co-trimoxazole, inhibits two sequential steps in the bacterial metabolism of folic acid. Trimethoprim is a pyrimidine inhibitor of dihydrofolate reductase; sulfamethoxazole is a sulfamide inhibitor of bacterial dihydrofolate synthetase. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:cotrimoxazole
Eslectin
insozalin
trimedin
trimezole
US brand names:Bactrim
Cotrim
Septra
Sulfamethoprim
Sulfatrim
Sulmeprim
Abbreviations:SMZ-TMP
TMP-SMX



Previous:Tricor, trifluoperazine hydrochloride, trifluridine, Trilisate, trilostane
Next:trimethylcolchicinic acid, trimetrexate glucuronate, Trimox, Triostat, triptorelin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov